PSYBF OTC
PsyBio Therapeutics Corp
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: -90.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$3M
+50.5% ▲
Capital Expenditures
$0
-100.0% ▼
Free Cash Flow
-$3M
+50.5% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$88K
+0.0% ▲
Net Change in Cash
$33K
+122.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$21K | -$16K | -$6M | -$11M | -$5M |
| Depreciation & Amort. | $0 | $0 | $0 | $0 | $152K |
| Stock-Based Comp. | $0 | $0 | $4M | $2M | $509K |
| Change in Working Capital | $7K | -$31K | $527K | $668K | $611K |
| Other Non-Cash Items | -$0 | $23K | $1M | $1M | $177K |
| Operating Cash Flow | -$14K | -$24K | -$864K | -$7M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $4K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $176K | $0 |
| Investment Purchases | $0 | $0 | $0 | -$8M | -$350K |
| Investment Sales | $0 | $0 | $0 | $4M | $4M |
| Other Investing | $0 | $0 | $0 | -$4K | $154K |
| Investing Cash Flow | $0 | $0 | $0 | -$4M | $4M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | -$123K |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$88K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $1M | -$908K | $0 |
| Financing Cash Flow | $0 | $0 | $1M | $10M | -$55K |
| Net Change in Cash | -$13K | -$32K | $294K | -$145K | $33K |
| Cash End of Period | $194K | $162K | $294 | $124K | $157K |
| Free Cash Flow | -$14K | -$24K | -$864K | -$7M | -$3M |